Form 4: Amgen Executive Murdo Gordon Reports Stock Disposal to Cover Tax Obligations

EVP Murdo Gordon disposed of 4,039 shares of Amgen common stock on March 17, 2025, to satisfy tax obligations related to vested restricted stock units.

Summary

• On March 17, 2025, Murdo Gordon, EVP, Global Commercial Operations at Amgen Inc., disposed of 4,039 shares of common stock.
• The transaction was executed to cover tax obligations.
• The price per share was $313.71.
• Following the transaction, Gordon directly owns 48,386 shares of Amgen common stock, which includes 868 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan.
• DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount.

Sentiment

Score: 5

Explanation: This is a neutral event. It's a routine transaction related to tax obligations and doesn't necessarily reflect a positive or negative outlook on the company.

Industry Context

Form 4 filings are a routine part of insider trading regulations, providing transparency into the transactions of company executives and directors. This specific filing indicates a common practice of executives selling shares to cover tax obligations arising from the vesting of stock awards.

Key Dates

Keywords

Form 4, Amgen, Murdo Gordon, Stock Disposal, Tax Obligations, EVP, Dividend Equivalents, Equity Incentive Plan